BeStock  
Stocks › Biotechnology › FTH

Faeth Therapeutics FTH

US equityMarket cap rank #3571Biotechnology
$24.92 −$1.97 (-7.33%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $24.92 0.00%
Open$26.71
Prev close$26.89
Day range$23.95 – $27.03
Volume322.6K
Market cap$643.94M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$18.39M-253.2% YoY
Net profit-$16.01M-224.3% YoY
Diluted EPS-$2.84+27.4% YoY
Free cash flow-$15.67M-164.5% YoY
Operating cash flow-$15.67M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-7.3MSep '24$-7.8MDec '24$-6.9MMar '25$-4.9MJun '25$-4.6MSep '25$-4.7MDec '25$-170.2MMar '26$-16.0MJun '26

Diluted EPS by quarter

-5.77Sep '24-6.17Dec '24-5.45Mar '25-3.91Jun '25-3.62Sep '25-3.74Dec '25-131.45Mar '26-2.84Jun '26

Free cash flow by quarter

$-5.5MSep '24$-5.8MDec '24$-7.1MMar '25$-5.9MJun '25$-3.6MSep '25$-3.9MDec '25$-10.7MMar '26$-15.7MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-195.3%
Return on assets-176.9%
Return on invested capital-195.4%
Current ratio19.69
Liabilities / assets8.6%
Cash & investments$186.44M
Total debt$0.00
Net cash (debt)$186.44M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $18.39M $170.63M $22.29M $4.96M $4.85M
Selling and Admin Expenses $9.21M $19.71M $11.33M $2.79M $2.32M
-General & Admin Expense $9.21M $19.71M $11.33M $2.79M $2.32M
Research & Development $9.18M $150.91M $10.96M $2.17M $2.54M
Operating Profit -$18.39M -$170.63M -$22.29M -$4.96M -$4.85M
Net Non-Operating Interest Income (Expense) $2.26M $392,000.00 $1.21M $220,000.00 $283,000.00
Non-Operating Interest Income $2.26M $392,000.00 $1.24M $223,000.00 $289,000.00
Other Income (Expense) $120,000.00 -$1,000.00 -$4,000.00 $20,000.00 -$1,000.00
Other Non-Operating Income (Expenses) $120,000.00 -$1,000.00 -$4,000.00 -$1,000.00 –
Pretax Profit -$16.01M -$170.24M -$21.09M -$4.72M -$4.57M
Net Profit -$16.01M -$170.24M -$21.09M -$4.72M -$4.57M
Profit from Continuing Operations -$16.01M -$170.24M -$21.09M -$4.72M -$4.57M
Net Income to Parent Company -$16.01M -$170.24M -$21.09M -$4.72M -$4.57M
Net Income to Common Stockholders -$16.01M -$170.24M -$21.09M -$4.72M -$4.57M
Basic EPS -$2.84 -$131.45 -$16.72 -$3.74 -$3.62
Diluted EPS -$2.84 -$131.45 -$16.72 -$3.74 -$3.62
Non-Operating Interest Expense – – $32,000.00 $3,000.00 $6,000.00
Special Income (Charges) – – $0.00 $21,000.00 -$1,000.00
-Less:Impairment of Capital Assets – – $0.00 – –
-Gain on Sale of Property/Plant/Equipment – – – – -$1,000.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $189.31M $205.38M $22.90M $22.90M $27.59M
Total Current Assets $188.66M $204.23M $21.51M $21.51M $25.79M
Cash and Cash Equivalents & Short-Term Investments $186.44M $202.79M $21.18M $21.18M $25.04M
-Cash and Cash Equivalents $26.90M $152.33M $8.67M $8.67M $10.56M
-Short Term Investments $159.54M $50.47M $12.52M $12.52M $14.48M
Prepaid Assets $1.36M $974,000.00 $231,000.00 $231,000.00 $496,000.00
Other Current Assets $858,000.00 $465,000.00 $92,000.00 $92,000.00 $248,000.00
Total Non-Current Assets $648,000.00 $1.15M $1.40M $1.40M $1.80M
Net PPE $568,000.00 $982,000.00 $1.38M $1.38M $1.79M
-Gross PPE $1.17M $1.56M $1.92M $1.92M $2.30M
-Accumulated Depreciation -$606,000.00 -$581,000.00 -$540,000.00 -$540,000.00 -$510,000.00
Other Non-Current Assets $80,000.00 $167,000.00 $18,000.00 $18,000.00 $18,000.00
Total Liabilities $16.35M $342.67M $4.31M $4.31M $4.58M
Total Current Liabilities $9.58M $14.19M $4.25M $4.25M $4.44M
Payables $2.15M $3.42M $689,000.00 $689,000.00 $306,000.00
-Accounts Payable $2.15M $3.42M $689,000.00 $689,000.00 $306,000.00
Current Accrued Expenses $5.25M $5.43M $715,000.00 $715,000.00 $1.02M
Short-Term Debt and Capital Lease Obligation $592,000.00 $1.04M $1.45M $1.45M $1.88M
-Current Capital Lease Obligation $592,000.00 $1.04M $1.45M $1.45M $1.88M
Other Current Liabilities $175,000.00 $136,000.00 $77,000.00 $77,000.00 $80,000.00
Total Non-Current Liabilities $6.77M $328.48M $59,000.00 $59,000.00 $146,000.00
Long Term Debt and Capital Lease Obligation $0.00 $1,000.00 $59,000.00 $59,000.00 $146,000.00
-Long Term Capital Lease Obligation $0.00 $1,000.00 $59,000.00 $59,000.00 $146,000.00
Convertible preferred securities $6.77M $328.48M – – –
Other Non-Current Liabilities $1,000.00 – – – –
Total Equity $172.96M -$137.29M $18.59M $18.59M $23.01M
Stockholders' Equity $172.96M -$137.29M $18.59M $18.59M $23.01M
Capital Stock $2,000.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $2,000.00 $0.00 $0.00 $0.00 $0.00
-Preferred Stock $0.00 – $0.00 $0.00 $0.00
Additional Paid-In Capital $642.40M $316.11M $301.73M $301.73M $301.43M
Retained Earnings -$469.38M -$453.37M -$283.14M -$283.14M -$278.42M
Gains/Losses Not Affecting Retained Earnings -$63,000.00 -$24,000.00 $1,000.00 $1,000.00 -$3,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$15.67M -$10.73M -$20.45M -$3.86M -$3.59M
Net cash flow from continuing operations -$15.67M -$10.73M -$20.45M -$3.86M -$3.59M
Net Income from Continuing Operations -$16.01M -$170.24M -$21.09M -$4.72M -$4.57M
Depreciation & Depletion & Amortization $25,000.00 $30,000.00 $139,000.00 $34,000.00 $34,000.00
Other Non-Cash Items $389,000.00 $133.34M $1.51M $374,000.00 $366,000.00
Change in Working Capital -$3.52M $13.32M -$1.59M $286,000.00 $469,000.00
-Change in Prepaid Assets -$384,000.00 $10.74M $243,000.00 $266,000.00 $331,000.00
-Change in Payables and Accrued Expense $243,000.00 -$104,000.00 $233,000.00 $77,000.00 $1.38M
-Change in Other Current Assets -$304,000.00 $442,000.00 $80,000.00 $178,000.00 -$126,000.00
-Change in Other Current Liabilities -$430,000.00 -$407,000.00 -$1.59M -$399,000.00 -$386,000.00
Net cash flow from investing -$108.07M -$31.44M $19.77M $2.08M $1.74M
Net Cash Flow from Continuing Investing Activities -$108.07M -$31.44M $19.77M $2.08M $1.74M
Net PPE Purchase and Sale $0.00 -$6,000.00 $234,000.00 $0.00 $0.00
Net Business Purchase and Sale $0.00 $6.46M – – –
Net Investment Purchase and Sale -$108.07M -$37.89M $19.54M $2.08M $1.74M
Financing Cash Flow -$1.68M $185.83M -$645,000.00 -$111,000.00 -$152,000.00
Net Cash Flow from Continuing Financing Activities -$1.68M $185.83M -$645,000.00 -$111,000.00 -$152,000.00
Net Issuance Payments Of Debt -$18,000.00 -$62,000.00 -$648,000.00 -$113,000.00 -$152,000.00
Net Preferred Stock Issuance -$1.76M $184.86M – – –
Proceeds from Stock Option Exercised $98,000.00 $1.03M $7,000.00 $2,000.00 $0.00
Ending Cash Balance $26.90M $152.33M $8.67M $8.67M $10.56M
Net Change in Cash -$125.42M $143.66M -$1.33M -$1.89M -$2.00M
Beginning Cash Balance $152.33M $8.67M $9.99M $10.56M $12.56M
Free Cash Flow -$15.67M -$10.74M -$20.47M -$3.86M -$3.59M
-Change In Other Working Capital – $2.65M -$562,000.00 $164,000.00 –
Net Common Stock Issuance – – -$1,000.00 $0.00 $0.00
Net Other Financing Charges – – -$3,000.00 $0.00 $0.00
Gain/Loss from Continuing Operations – – – – $1,000.00

Discussion

No comments yet — be the first to weigh in on FTH.

Leave a comment

Scroll to Top